The application and research progress of patient-reported outcomes in oncology drug clinical trials
WANG Yongqi
YANG Funa
LIU Yanyan
WANG Jianli
Abstract：In recent years,the application of patient self-reported outcomes(PROs)in clinical trials of cancer drugs has gradually become a research hotspot.PROs have become an important supplement to traditional medical indicators and play a key role in quality of life assessment,symptom monitoring,risk prediction,clinical decision support,and new drug approval.However,the current application of PROs still faces problems such as scale selection,data collection and management,data interpretation and standardization,which limits their comprehensive promotion in clinical practice.This paper aims to systematically sort out the application status,problems,and improvement direction of PROs in clinical trials of cancer drugs,and provide a theoretical basis and practical reference for researchers in the field of oncology drug clinical trials in China,so as to further improve the safe and quality of life of patients.
Keywords：oncologydrug clinical trialspatient-reported outcomesreview
Publication Date：2025-11-28
Online Publishing Date：2026-01-05(First online date of this platform, not the publication date of the document)
Pages：5( 1138-1142 )